p.124 抽出テキスト

30019463 195. Antolovic D, Rakow A, Contin P, et al. A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007). Langenbecks Arch Surg 2012; 397: 297-306. PMID: 22048442 196. Chu EW, Chernoguz A, Divino CM. The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial. Am J Surg 2016; 211: 1019-1025. PMID: 27002953 197. Mantz J, Samama CM, Tubach F, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth 2011; 107: 899-910. PMID: 21873632 198. Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy: a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 2000; 34: 194- 198. PMID: 10961474 199. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305- 312. PMID: 20150346 200. Devereaux PJ, Mrkobrada M, Sessler DI, et al. POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494-1503. PMID: 24679062 201. Devereaux PJ. POISE-2 Investigators. Rationale and design of the PeriOperative ISchemic Evaluation- 2 (POISE- 2) trial: An international 2 × 2 factorial randomized controlled trial of acetylsalicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J 2 0 1 4 ; 1 6 7 : 804-809. PMID: 24890528 202. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010; 138: 1093-1100. PMID: 20299623 203. 日本循環器学会 / 日本不整脈心電学会.2020 年改訂版 不整脈薬物治療ガイドライン.2020.https://www.j-circ.or.jp/cms/ wp-content/uploads/2020/01/JCS2020_Ono.pdf 204. Omran H, Bauersachs R, Rübenacker S, et al. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012; 108: 65-73. PMID: 22534746 205. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2 0 0 1 ; 2 8 5 : 2864-2870. PMID: 11401607 206. Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011; 58: 395-401. PMID: 21757117 207. OʼBrien EC, Simon DN, Thomas LE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J 2015; 36: 3258-3264. PMID: 26424865 208. Rossini R, Musumeci G, Visconti LO, et al. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014; 10: 38- 46. PMID: 24832636 209. Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018; 39: 1330-1393. PMID: 29562325 210. 日本循環器学会.2020年JCS ガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法.2020.https://www. j-circ.or.jp/cms/wp-content/uploads/ 2 0 2 0 / 0 4 /JCS 2 0 2 0 _ Kimura_Nakamura.pdf 211. Doherty JU, Gluckman TJ, Hucker WJ, et al. 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol 2017; 69: 871-898. PMID: 28081965 212. Online Appendix Common Procedures and Associated Proced u r a l B l e e d R i s k ( 2 0 1 7 A C C E x p e r t C o n s e n s u s Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation. J Am Coll Cardiol. 2017; 69: 871- 898. PMID: 28081965) http:// jaccjacc.acc.org/Clinical_Document/PMAC_Online_ Appendix.pdf 213. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9 th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 Suppl: e 326S-e 350S. PMID: 22315266 214. Suzuki S, Yamashita T, Okumura K, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy: Pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 2015; 79: 432-438. PMID: 25501800 215. Schulman S, Rhedin AS, Lindmarker P, et al. Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-1665. PMID: 7760866 216. 日本循環器学会.肺血栓塞栓症および深部静脈血栓症の診断,治療,予防に関するガイドライン(2017 年改訂版).2018.https:// www.j-circ.or.jp/cms/wp-content/uploads/ 2017/ 09/JCS 2017_ ito_h.pdf 217. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 Suppl: e419S-e496S. PMID: 22315268 218. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2 0 0 6 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1 9 9 8 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231. PMID: 16880336 219. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641. PMID: 8313552 220. Mérie C, Køber L, Skov Olsen P, et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 2012; 308: 2118-2125. PMID: 23188028 221. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995; 25: 1111-1119. PMID: 7897124 222. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658- 1663. PMID: 15364803 223. Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2 0 0 5 ; 1 2 7 : 922-927. PMID: 15764777 224. Spyropoulos AC, Al-Badri A, Sherwood MW, et al. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost 2 0 1 6 ; 1 4 : 8 7 5 - 8 8 5 . PMID: 26988871 225. Douketis JD, Spyropoulos AC, Kaatz S, et al. BRIDGE Investigators. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med 2015; 373: 823- 833. PMID: 26095867 226. Douketis JD, Healey JS, Brueckmann M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 2015; 113: 625-632. PMID: 25472710 227. Sjögren V, Grzymala-Lubanski B, Renlund H, et al. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study. Clin Appl Thromb Hemost 2017; 23: 961- 966. PMID: 28468510 228. Steinberg BA, Peterson ED, Kim S, et al. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation